| abstract |
The present invention belongs to the pharmaceutical field, and provides crystalline forms, solvates and the crystalline forms thereof of the compound (S)-4-amino-6- ( (1- (3-chloro-6-phenylimidazo [1, 2-b] pyridazin-7-yl) ethyl) amino) pyrimidine-5-carbonitrile, and the pharmaceutical compositions comprising the same as well as the methods of preparing the same and the use thereof. |